NCT04287881View on ClinicalTrials.gov

Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

February 15, 2020

Study Completion Date

February 20, 2020

Conditions
Hyperhomocysteinemia, Thrombotic, Cbs-RelatedIschemic StrokeEpilepsy
Interventions
GENETIC

Methylenetetrahydrofolate reductase (MTHFR) deficiency

To investigate the incidence of MTHFR deficiency in patients with adult-onset epileptic seizures and diagnosed ischemic stroke

Trial Locations (2)

34722

Zeynep Orhon, Istanbul

34730

Istanbul MU Goztepe Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Medeniyet University

OTHER

NCT04287881 - Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke | Biotech Hunter | Biotech Hunter